US Stock MarketDetailed Quotes
BIOCQ BIOCEPT INC
- 0.000
- 0.0000.00%
15min DelayClose Nov 27 16:00 ET
262.60Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)2.63MShares0.12552wk High0.00P/B262.60Float Cap0.00052wk Low--Dividend TTM2.63MShs Float270540.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
BIOCEPT INC Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -89.88%589K | -96.63%673K | -57.78%25.86M | -106.53%-913K | -94.24%1.01M | -51.70%5.82M | 12.33%19.95M | 123.04%61.25M | -24.50%13.98M | 165.25%17.47M |
| Operating revenue | -89.88%589K | -96.63%673K | -57.78%25.86M | -106.53%-913K | -94.24%1.01M | -51.70%5.82M | 12.33%19.95M | 123.04%61.25M | -24.50%13.98M | 165.25%17.47M |
| Cost of revenue | -68.22%2.55M | -70.70%3.03M | -24.69%28.44M | -57.05%4.31M | -48.73%5.78M | 7.52%8.02M | 14.75%10.33M | 76.99%37.76M | 0.18%10.03M | 92.26%11.27M |
| Gross profit | 11.03%-1.96M | -124.50%-2.36M | -110.99%-2.58M | -232.34%-5.22M | -176.86%-4.77M | -148.07%-2.2M | 9.84%9.61M | 283.49%23.49M | -53.57%3.95M | 753.77%6.21M |
| Operating expense | -45.96%4.15M | -59.67%4.74M | 13.54%29.4M | -32.03%4.57M | -20.24%5.39M | 21.35%7.69M | 93.23%11.76M | 19.92%25.89M | 2.90%6.72M | 21.81%6.76M |
| Selling and administrative expenses | -37.14%3.74M | -62.65%3.7M | 11.02%23.24M | -36.17%3.35M | -26.23%4.02M | 14.63%5.96M | 96.59%9.91M | 27.86%20.93M | -1.07%5.24M | 22.30%5.45M |
| -Selling and marketing expense | -84.90%250K | -80.45%715K | -14.34%7.13M | -66.71%837K | -49.69%975K | -14.86%1.66M | 90.22%3.66M | 30.00%8.32M | 16.01%2.51M | 35.10%1.94M |
| -General and administrative expense | -18.74%3.49M | -52.24%2.99M | 27.74%16.11M | -8.06%2.51M | -13.29%3.05M | 32.27%4.3M | 100.51%6.26M | 26.48%12.61M | -12.88%2.73M | 16.23%3.51M |
| Research and development costs | -76.34%409K | -43.66%1.04M | 24.21%6.16M | -17.33%1.22M | 4.83%1.37M | 52.07%1.73M | 76.99%1.85M | -4.98%4.96M | 20.00%1.48M | 19.79%1.3M |
| Operating profit | 38.17%-6.11M | -230.29%-7.1M | -1,227.65%-31.98M | -252.63%-9.79M | -1,746.73%-10.16M | -465.73%-9.89M | -180.67%-2.15M | 84.43%-2.41M | -241.20%-2.78M | 88.59%-550K |
| Net non-operating interest income expense | 67.74%-50K | 24.59%-46K | -8.97%-316K | 32.86%-47K | 30.67%-52K | -93.75%-155K | 6.15%-61K | -22.88%-290K | -9.19%-70K | -25.95%-75K |
| Non-operating interest expense | -67.74%50K | -24.59%46K | 8.97%316K | -32.86%47K | -30.67%52K | 93.75%155K | -6.15%61K | 22.88%290K | 9.19%70K | 25.95%75K |
| Other net income (expense) | 2.53M | 87K | 3K | 84K | ||||||
| Gain on sale of security | --2.44M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | --91K | ---- | --87K | --3K | --84K | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 63.85%-3.63M | -223.26%-7.14M | -1,093.48%-32.21M | -245.50%-9.83M | -1,520.00%-10.13M | -449.45%-10.04M | -185.03%-2.21M | 84.84%-2.7M | -249.63%-2.85M | 87.19%-625K |
| Income tax | 0 | 0 | -200.00%-125K | -200.00%-125K | 0 | 0 | 0 | 125K | 125K | 0 |
| Net income | 63.85%-3.63M | -223.26%-7.14M | -1,036.23%-32.09M | -226.76%-9.71M | -1,520.00%-10.13M | -449.45%-10.04M | -185.03%-2.21M | 84.14%-2.82M | -256.21%-2.97M | 87.19%-625K |
| Net income continuous Operations | 63.85%-3.63M | -223.26%-7.14M | -1,036.23%-32.09M | -226.76%-9.71M | -1,520.00%-10.13M | -449.45%-10.04M | -185.03%-2.21M | 84.14%-2.82M | -256.21%-2.97M | 87.19%-625K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 63.85%-3.63M | -223.26%-7.14M | -1,036.23%-32.09M | -226.76%-9.71M | -1,520.00%-10.13M | -449.45%-10.04M | -185.03%-2.21M | 84.14%-2.82M | -256.21%-2.97M | 87.19%-625K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 63.85%-3.63M | -223.26%-7.14M | -1,036.23%-32.09M | -226.76%-9.71M | -1,520.00%-10.13M | -449.45%-10.04M | -185.03%-2.21M | 84.14%-2.82M | -256.22%-2.97M | 87.19%-625K |
| Basic earnings per share | 80.36%-3.5 | -215.38%-12.3 | -894.74%-56.7 | -216.67%-17.1 | -1,400.00%-18 | -324.29%-17.82 | -168.42%-3.9 | 87.33%-5.7 | -228.57%-5.4 | 89.19%-1.2 |
| Diluted earnings per share | 80.36%-3.5 | -215.38%-12.3 | -894.74%-56.7 | -216.67%-17.1 | -1,400.00%-18 | -324.29%-17.82 | -168.42%-3.9 | 87.33%-5.7 | -228.57%-5.4 | 89.19%-1.2 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
